Background: A bone conducting implant is a treatment option for individuals with conductive or mixed hearing loss (CHL, MHL) who do not tolerate regular hearing aids, and for individuals with single-sided deafness (SSD). An active bone conducting implant (ABCI) was introduced in 2012 with indication in CHL, MHL, and SSD, and it is still the only ABCI available. With complete implantation of the active transducer and consequent intact skin, a decrease in infections, skin overgrowth, and implant losses, all common disadvantages with earlier passive bone conducting implants, could be expected. Our Ear, Nose and Throat Department, a secondary care center for otosurgery that covers a population of approximately 365,000 inhabitants, was approved to implant ABCIs in 2012. Objectives: Our aim was to conduct an evaluation of audiological and subjective outcomes after ABCIs. Method: A cohort study with retrospective and prospective data collection was performed. The first 20 consecutive patients operated with an ABCI were asked for informed consent. The main outcome measures were pure tone and speech audiometry and the Glasgow Benefit Inventory (GBI). Results: Seventeen patients accepted to participate and 15 were able to complete all parts. Six patients had CHL or MHL. In this group the pure tone audiometry tests are comparable with an average functional hearing gain of 29.8 dB HL. With bilateral hearing, the mean Word Recognition Score (WRS) in noise was 35.7% unaided and 62.7% aided. Ten patients had the indication SSD. With the hearing ear blocked, the pure tone average was >101 dB HL, compared to 29.3 dB HL in sound field aided. With bilateral hearing, the mean WRS in noise was 59.7% unaided and 72.8% aided. The mean of the total GBI score was 42.1 in the group with CHL or MHL and 20.6 in the group with SSD. Conclusions: The patients benefit from their implants in terms of quality of life, and there is a substantial hearing gain from the implant for patients with conductive or MHL. Patients with SSD benefit less from the implant than other diagnoses but the positive outcomes are comparable to other options for this group.

1.
Hagerman
B
.
Reliability in the determination of speech reception threshold (SRT)
.
Scand Audiol
.
1979
;
8
(
4
):
195
202
.
[PubMed]
0105-0397
2.
Håkansson
B
,
Tjellström
A
,
Rosenhall
U
,
Carlsson
P
.
The bone-anchored hearing aid. Principal design and a psychoacoustical evaluation
.
Acta Otolaryngol
.
1985
Sep-Oct
;
100
(
3-4
):
229
39
.
[PubMed]
0001-6489
3.
Hassepass
F
,
Bulla
S
,
Aschendorff
A
,
Maier
W
,
Traser
L
,
Steinmetz
C
, et al
The bonebridge as a transcutaneous bone conduction hearing system: preliminary surgical and audiological results in children and adolescents
.
Eur Arch Otorhinolaryngol
.
2015
Sep
;
272
(
9
):
2235
41
.
[PubMed]
0937-4477
4.
Hendry
J
,
Chin
A
,
Swan
IR
,
Akeroyd
MA
,
Browning
GG
.
The Glasgow Benefit Inventory: a systematic review of the use and value of an otorhinolaryngological generic patient-recorded outcome measure
.
Clin Otolaryngol
.
2016
Jun
;
41
(
3
):
259
75
.
[PubMed]
1749-4478
5.
Ihler
F
,
Volbers
L
,
Blum
J
,
Matthias
C
,
Canis
M
.
Preliminary functional results and quality of life after implantation of a new bone conduction hearing device in patients with conductive and mixed hearing loss
.
Otol Neurotol
.
2014
Feb
;
35
(
2
):
211
5
.
[PubMed]
1531-7129
6.
Kiringoda
R
,
Lustig
LR
.
A meta-analysis of the complications associated with osseointegrated hearing aids
.
Otol Neurotol
.
2013
Jul
;
34
(
5
):
790
4
.
[PubMed]
1531-7129
7.
Magnusson
L
.
Reliable clinical determination of speech recognition scores using Swedish PB words in speech-weighted noise
.
Scand Audiol
.
1995
;
24
(
4
):
217
23
.
[PubMed]
0105-0397
8.
Martin
TP
,
Lowther
R
,
Cooper
H
,
Holder
RL
,
Irving
RM
,
Reid
AP
, et al
The bone-anchored hearing aid in the rehabilitation of single-sided deafness: experience with 58 patients
.
Clin Otolaryngol
.
2010
Aug
;
35
(
4
):
284
90
.
[PubMed]
1749-4478
9.
Monini
S
,
Bianchi
A
,
Talamonti
R
,
Atturo
F
,
Filippi
C
,
Barbara
M
.
Patient satisfaction after auditory implant surgery: ten-year experience from a single implanting unit center
.
Acta Otolaryngol
.
2017
Apr
;
137
(
4
):
389
97
.
[PubMed]
0001-6489
10.
Pai
I
,
Kelleher
C
,
Nunn
T
,
Pathak
N
,
Jindal
M
,
O’Connor
AF
, et al
Outcome of bone-anchored hearing aids for single-sided deafness: a prospective study
.
Acta Otolaryngol
.
2012
Jul
;
132
(
7
):
751
5
.
[PubMed]
0001-6489
11.
Riss
D
,
Arnoldner
C
,
Baumgartner
WD
,
Blineder
M
,
Flak
S
,
Bachner
A
, et al
Indication criteria and outcomes with the Bonebridge transcutaneous bone-conduction implant
.
Laryngoscope
.
2014
Dec
;
124
(
12
):
2802
6
.
[PubMed]
0023-852X
12.
Robinson
K
. (
2017
). "
THE GLASGOW HEALTH STATUSQUESTIONNAIRES MANUAL.
" Retrieved February 2, 2019, from http://studylib.net/doc/8450311/the-health-status-questionnaires-manual
13.
Robinson
K
,
Gatehouse
S
,
Browning
GG
.
Measuring patient benefit from otorhinolaryngological surgery and therapy
.
Ann Otol Rhinol Laryngol
.
1996
Jun
;
105
(
6
):
415
22
.
[PubMed]
0003-4894
14.
Salcher
R
,
Zimmermann
D
,
Giere
T
,
Lenarz
T
,
Maier
H
.
Audiological Results in SSD With an Active Transcutaneous Bone Conduction Implant at a Retrosigmoidal Position
.
Otol Neurotol
.
2017
Jun
;
38
(
5
):
642
7
.
[PubMed]
1531-7129
15.
Schmerber
S
,
Deguine
O
,
Marx
M
,
Van de Heyning
P
,
Sterkers
O
,
Mosnier
I
, et al
Safety and effectiveness of the Bonebridge transcutaneous active direct-drive bone-conduction hearing implant at 1-year device use
.
Eur Arch Otorhinolaryngol
.
2017
Apr
;
274
(
4
):
1835
51
.
[PubMed]
0937-4477
16.
Sprinzl
G
,
Lenarz
T
,
Ernst
A
,
Hagen
R
,
Wolf-Magele
A
,
Mojallal
H
, et al
First European multicenter results with a new transcutaneous bone conduction hearing implant system: short-term safety and efficacy
.
Otol Neurotol
.
2013
Aug
;
34
(
6
):
1076
83
.
[PubMed]
1531-7129
17.
Sprinzl
GM
,
Wolf-Magele
A
.
The Bonebridge Bone Conduction Hearing Implant: indication criteria, surgery and a systematic review of the literature
.
Clin Otolaryngol
.
2016
Apr
;
41
(
2
):
131
43
.
[PubMed]
1749-4478
18.
Tsang
WS
,
Yu
JK
,
Bhatia
KS
,
Wong
TK
,
Tong
MC
.
The Bonebridge semi-implantable bone conduction hearing device: experience in an Asian patient
.
J Laryngol Otol
.
2013
Dec
;
127
(
12
):
1214
21
.
[PubMed]
0022-2151
19.
Vaneecloo
FM
,
Ruzza
I
,
Hanson
JN
,
Gérard
T
,
Dehaussy
J
,
Cory
M
, et al
[The monaural pseudo-stereophonic hearing aid (BAHA) in unilateral total deafness: a study of 29 patients]
.
Rev Laryngol Otol Rhinol (Bord)
.
2001
;
122
(
5
):
343
50
.
[PubMed]
0035-1334
20.
Wazen
JJ
,
Van Ess
MJ
,
Alameda
J
,
Ortega
C
,
Modisett
M
,
Pinsky
K
.
The Baha system in patients with single-sided deafness and contralateral hearing loss
.
Otolaryngol Head Neck Surg
.
2010
Apr
;
142
(
4
):
554
9
.
[PubMed]
0194-5998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.